<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have reported potential roles of angiotensins in an adaptative physiological mechanism of protection against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-induced neurological damages </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we examined the protective role of angiotensin IV (AngIV) in a rat model of embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> induced by intracarotid injection of calibrated microspheres (50 microm) </plain></SENT>
<SENT sid="2" pm="."><plain>Internal carotid infusions of increasing doses of AngIV (0.01, 0.1 and 1 nmol/0.1 mL saline) dose dependently decreased mortality, neurological deficit and cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size at 24 hours </plain></SENT>
<SENT sid="3" pm="."><plain>With the highest dose of AngIV, mortality was reduced from 55 % in saline infused controls to 10 % (p=0.003), neurological deficit was reduced from 3.8 +/- 0.3 to 1.4 +/- 0.3 , (p&lt;0.0001) and cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size at 24 hours was decreased from 432 +/- 26 mm(3) to 185 +/- 19, (p=0.0001) </plain></SENT>
<SENT sid="4" pm="."><plain>The AT(4) <z:chebi fb="68" ids="48706">antagonist</z:chebi> divalinal-AngIV (10(-9) mol/0.1 mL), or pretreatment with L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (10(-7) mol/0.1 mL), both completely abolished the protective effect of AngIV (1 nmol) </plain></SENT>
<SENT sid="5" pm="."><plain>The AT(2) <z:chebi fb="68" ids="48706">antagonist</z:chebi> PD123319 (10(-7) mol/0.1 mL) partially prevented the protective effect of AngIV on the neurological score </plain></SENT>
<SENT sid="6" pm="."><plain>Sequential cerebral arteriographies revealed that AngIV induced a redistribution of blood flow to the ischemic areas within minutes </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that pharmacological doses of AngIV are protective against <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by triggering an AT(4)-mediated, NO-dependent intracerebral hemodynamic mechanism </plain></SENT>
</text></document>